Incidence rates of tenosynovial giant cell tumor, overall and by calendar year, sex, and age group, Denmark, 1997–2012.
| Variables | L-TGCT | D-TGCT | ||||
|---|---|---|---|---|---|---|
| New Cases, n | Person-yrs | Incidence Rate/106 Person-yrs (95% CI) | New Cases, n | Person-yrs | Incidence Rate/106 Person-yrs (95% CI) | |
| Overall | 2087 | 68,754,326 | 30.3 (29.1–31.7) | 574 | 68,765,012 | 8.4 (7.7–9.1) |
| Calendar yr | ||||||
| 1997 | 106 | 4,222,359 | 25.1 (20.6–30.4) | 26 | 4,222,400 | 6.2 (4.0–9.0) |
| 1998 | 95 | 4,232,152 | 22.4 (18.2–27.4) | 24 | 4,232,267 | 5.7 (3.6–8.4) |
| 1999 | 94 | 4,236,593 | 22.2 (17.9–27.2) | 32 | 4,236,772 | 7.6 (5.2–10.7) |
| 2000 | 118 | 4,252,658 | 27.8 (23.0–33.2) | 50 | 4,252,907 | 11.8 (8.7–15.5) |
| 2001 | 123 | 4,244,689 | 29.0 (24.1–34.6) | 33 | 4,245,007 | 7.8 (5.4–10.9) |
| 2002 | 141 | 4,247,509 | 33.2 (27.9–39.2) | 41 | 4,247,923 | 9.6 (6.9–13.1) |
| 2003 | 133 | 4,249,333 | 31.3 (26.2–37.1) | 49 | 4,249,843 | 11.5 (8.5–15.2) |
| 2004 | 131 | 4,265,012 | 30.7 (25.7–36.4) | 43 | 4,265,599 | 10.1 (7.3–13.6) |
| 2005 | 169 | 4,260,212 | 39.7 (33.9–46.1) | 32 | 4,260,910 | 7.5 (5.1–10.6) |
| 2006 | 134 | 4,270,779 | 31.4 (26.3–37.2) | 23 | 4,271,603 | 5.4 (3.4–8.1) |
| 2007 | 121 | 4,287,730 | 28.2 (23.4–33.7) | 36 | 4,288,643 | 8.4 (5.9–11.6) |
| 2008 | 93 | 4,323,889 | 21.5 (17.4–26.4) | 37 | 4,324,877 | 8.6 (6.0–11.8) |
| 2009 | 154 | 4,335,069 | 35.5 (30.1–41.6) | 42 | 4,336,121 | 9.7 (7.0–13.1) |
| 2010 | 149 | 4,356,229 | 34.2 (28.9–40.2) | 49 | 4,357,381 | 11.2 (8.3–14.9) |
| 2011 | 138 | 4,379,582 | 31.5 (26.5–37.2) | 29 | 4,380,823 | 6.6 (4.4–9.5) |
| 2012 | 188 | 4,414,105 | 42.6 (36.7–49.1) | 28 | 4,415,486 | 6.3 (4.2–9.2) |
| Sex | ||||||
| Women | 1274 | 35,003,696 | 36.4 (34.4–38.4) | 295 | 35,010,704 | 8.43 (7.5–9.4) |
| Men | 813 | 33,750,630 | 24.1 (22.5–25.8) | 279 | 33,754,307 | 8.27 (7.3–9.3) |
| Age at diagnosis, yrs | ||||||
| 18–19 | 23 | 2,032,695 | 11.3 (7.2–17.0) | 13 | 2,032,706 | 6.4 (3.4–10.9) |
| 20–39 | 720 | 22,404,162 | 32.1 (29.8–34.6) | 187 | 22,406,852 | 8.4 (7.2–9.6) |
| 40–59 | 883 | 23,305,412 | 37.9 (35.4–40.5) | 231 | 23,309,694 | 9.9 (8.7–11.3) |
| 60–79 | 436 | 14,618,601 | 29.8 (27.1–32.8) | 122 | 14,621,563 | 8.3 (6.9–10.0) |
| ≥ 80 | 25 | 3,526,253 | 7.1 (4.6–10.5) | 21 | 3,526,464 | 5.9 (3.7–9.1) |
L-TGCT: localized tenosynovial giant cell tumor; D-TGCT: diffuse tenosynovial giant cell tumor.